You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

brolucizumab

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Wet Age-related Macular Degeneration Trial in Bern (Aflibercept, Brolucizumab, early treat and extend (T&E))

Enrolling by invitation
  • Wet Age-related Macular Degeneration
  • Bern, Switzerland
    Berner Augenklinik am Lindenhofspital
May 13, 2022

Fluid Resolution and Effectiveness of Brolucizumab for nAMD in

Recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • Brolucizumab
  • Funchal, Portugal
  • +11 more
Jun 9, 2022

Diabetic Macular Edema Trial in China (Brolucizumab, Aflibercept)

Active, not recruiting
  • Diabetic Macular Edema
  • Guangzhou, Guangdong, China
  • +23 more
Jan 20, 2023

Neovascular Age-related Macular Degeneration

Completed
  • Age-related Macular Degeneration (AMD)
  • Brolucizumab
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Neovascular Age-related Macular Degeneration

Completed
  • Age-related Macular Degeneration (AMD)
  • Brolucizumab
  • East Hanover, New Jersey
    Novartis Pharmaceuticals
Oct 19, 2021

Neovascular Age-related Macular Degeneration Trial in Italy (Brolucizumab)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Brolucizumab
  • Ancona, AN, Italy
  • +18 more
Aug 10, 2022

Age-Related Macular Degeneration Trial in Hong Kong (Brolucizumab, Aflibercept)

Recruiting
  • Age-Related Macular Degeneration
  • Hong Kong, Hong Kong
    Grantham Hospital
Jan 25, 2023

Age-related Macular Degeneration (AMD) Trial (brolucizumab)

Withdrawn
  • Age-related Macular Degeneration (AMD)
  • brolucizumab
  • (no location specified)
Sep 21, 2021

Number of Patient Eyes That Remained on or Switched to Anti-VEGF

Completed
  • Age-related Macular Degeneration (AMD)
  • Brolucizumab
  • East Hanover, New Jersey
    Novartis Investigational site
Oct 6, 2021

Diabetic Macula Edema Trial (Brolucizumab, Aflibercept)

Withdrawn
  • Diabetic Macula Edema
  • (no location specified)
Mar 2, 2021

Neovascular Age-related Macular Degeneration Trial in Worldwide (brolucizumab)

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • brolucizumab
  • Huntington Beach, California
  • +59 more
Jan 20, 2023

Patients Receiving Beovu in Neovascular Age-related Macular

Recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • brolucizumab
  • Luedenscheid, NRW, Germany
  • +48 more
Sep 16, 2022

Automated Optical Coherence Tomography Image Enrichment With

Active, not recruiting
  • Neovascular Age-Related Macular Degeneration
  • brolucizumab
  • +2 more
  • Hamilton, Ontario, Canada
  • +16 more
Aug 8, 2022